PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹262.00bn
- IN₹304.53bn
- IN₹88.69bn
India's Piramal Pharma slides 13% in seven days to record low
India's Piramal Pharma sees best day in over 2 weeks
Brief: Piramal Pharma Us FDA Inspection Has Now Been Closed, Issued Establishment Inspection Report
Brief: Piramal Pharma Us FDA Conducted Pre-Approval Inspection And Good Manufacturing Practices Inspection Of Lexington Facility
Jefferies initiates Piramal Pharma at 'buy' rating
India's Piramal Pharma up on anti-dumping probe on Vitamin A-Palmitate imports
Brief: Piramal Pharma Limited Lists On BSE And NSE